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Abstract
Background: The HLA (human leukocyte antigen) molecules that present pathogen-derived epitopes to T cells are
highly diverse. Correspondingly, many pathogens such as HIV evolve epitope variants in order to evade immune
recognition. In contrast, another persistent human pathogen, Mycobacterium tuberculosis, has highly conserved
epitope sequences. This raises the question whether there is also a difference in the ability of these pathogens’
epitopes to bind diverse HLA alleles, referred to as an epitope’s binding promiscuity. To address this question, we
compared the in silico HLA binding promiscuity of T cell epitopes from pathogens with distinct infection strategies and
outcomes of human exposure.
Methods: We used computer algorithms to predict the binding affinity of experimentally-verified microbial epitope
peptides to diverse HLA-DR, HLA-A and HLA-B alleles. We then analyzed binding promiscuity of epitopes derived
from HIV and M. tuberculosis. We also analyzed promiscuity of epitopes from Streptococcus pyogenes, which is
known to exhibit epitope diversity, and epitopes of Bacillus anthracis and Clostridium tetani toxins, as these bacteria
do not depend on human hosts for their survival or replication, and their toxin antigens are highly immunogenic
human vaccines.
Results: We found that B. anthracis and C. tetani epitopes were the most promiscuous of the group that we
analyzed. However, there was no consistent difference or trend in promiscuity in epitopes contained in HIV, M.
tuberculosis, and S. pyogenes.
Conclusions: Our results show that human pathogens with distinct immune evasion strategies and epitope
diversities exhibit equivalent levels of T cell epitope promiscuity. These results indicate that differences in epitope
promiscuity do not account for the observed differences in epitope variation and conservation.
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Introduction
MHC (major histocompatibility complex) molecules recognize
and bind epitopes derived from foreign and self proteins in
order to initiate and maintain adaptive immune responses. The
HLA (human leukocyte antigen) alleles that encode MHC
molecules are extremely diverse: over 2000 HLA class I, and
over 600 HLA class II alleles have been identified [1]. In a
model of host–pathogen coevolution, this diversity is
maintained through selection for individuals with heterozygous
HLA alleles and/or for individuals with rare HLA alleles [2].
Individuals heterozygous for HLA alleles produce a greater
diversity of HLA molecules, and therefore may develop an
immune response against a greater breadth of pathogen
epitopes [3,4]. In addition, pathogens are more likely to develop
adaptations in response to the most common HLA alleles in a
population, and therefore individuals with rare alleles may have
a selective advantage [5]. A common adaptation used by
pathogens to avoid immune recognition is antigenic variation,
in which epitope variants that decrease the likelihood of HLA
binding are selected [6]. Human immunodeficiency virus (HIV)
is an extreme example; new variants appear at each
successive generation, which eventually leads to immune
evasion and disease progression, and has frustrated vaccine
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development efforts [7]. In this way, hosts and their pathogens
can be locked in a never-ending “arms race” to diversify their
HLA allele or epitope sequences, respectively. This is known
as antagonistic coevolution, or the Red Queen model [5,6].
We recently reported that Mycobacterium tuberculosis, a
highly successful persistent human pathogen, has highly
conserved epitope sequences [8]. This apparently conflicts with
the general model of a host–pathogen coevolution, and
emphasizes that M. tuberculosis employs unique approaches
to achieve success as a pathogen.
It has also been shown in a variety of pathogens that, even
though the adaptive immune response is highly specific,
individual HLA class II-restricted peptides [9-13] and HLA class
I-restricted peptides [14-18] may bind many different HLA
alleles; a trait termed epitope promiscuity. Given the extensive
human HLA allele diversity and varied pathogen epitope
diversity, we were interested in determining whether the extent
of epitope promiscuity varies in pathogens with distinct
ecological niches and interactions with human hosts.
We compared epitope promiscuity in M. tuberculosis and
HIV, since these human-specific pathogens vary in their
epitope diversity [7,19] yet both persist in the face of antigen-
specific T cell responses. For contrast, we examined
Streptococcus pyogenes, which undergoes antigenic variation
[20], but is not able to persist within a host [21], and we
examined three vaccine antigens from Bacillus anthracis and
Clostridium tetani.
We used the computer algorithms NetMHCpan-2.0 and
NetMHCIIpan-2.0 to predict the binding affinity of
experimentally determined microbial epitopes to HLA-DR, HLA-
A, and HLA-B alleles [22,23]. We then analyzed epitope
promiscuity across the majority of human HLA alleles, across
the most common HLA alleles found in different geographic
regions, and across alleles grouped by similar characteristics.
We find that epitopes from B. anthracis and C. tetani are
consistently the most promiscuous, and that there is no
consistent pattern of promiscuity between M. tuberculosis, HIV
and S. pyogenes. Therefore we find similar levels of epitope
promiscuity in very different pathogens, and we discuss the
impact of promiscuity on host–pathogen coevolution.
Methods
Programs and databases
NetMHCpan-2.0.  The NetMHCpan-2.0 algorithm (http://
www.cbs.dtu.dk/services/NetMHCpan-2.0/) uses an artificial
neural network (ANN) to predict the binding affinity of peptide-
MHC (HLA)-I molecule interactions [22,23]. Peptide sequence
and HLA sequence information were used as input and
experimentally determined affinity data from the IEDB database
covering 34 HLA-A and 32 HLA-B alleles were used as output
to train the ANN. This method currently gives affinity estimates
for peptides with 886 HLA-A alleles and 1,412 HLA-B alleles.
NetMHCIIpan-2.0.  The NetMHCIIpan-2.0 algorithm (http://
www.cbs.dtu.dk/services/NetMHCIIpan/) uses an ANN to
predict the binding affinity of peptide-MHC (HLA)-II molecule
interactions [22,23]. Peptide sequence and HLA sequence
information were used as input and experimentally determined
affinity data from the IEDB database covering 24 HLA-DR
alleles were used as output to train the ANN. This method
currently provides binding affinity data for 654 HLA-DR alleles.
IEDB.  The IEDB (Immune Epitope Database, http://
www.immuneepitope.org/) contains peptidic and non-peptidic
antibody and T cell epitope data for humans and other animal
species. The database contains HLA binding data from diverse
antigenic sources, including allergens and multiple human
pathogens. It also provides tools for epitope prediction and
analysis.
HIV Molecular Immunology Database.  The HIV Molecular
Immunology Database (http://www.hiv.lanl.gov/content/
immunology/index.html) contains data on HIV T cell epitopes,
and provides access to tools for epitope prediction and
analysis.
dbMHC.  The dbMHC (http://www.ncbi.nlm.nih.gov/
projects/gv/mhc/main.fcgi?cmd=init) contains DNA seqeuence
and other data related to the human MHC, including
anthropology resources regarding the distribution and
frequency of specific HLA alleles in multiple populations.
Alleles and epitopes used in the study
Epitopes were obtained from the IEDB for all bacterial
species, and the HIV Molecular Immunology Database for HIV
epitopes. All HLA alleles included in netMHCpan and
netMHCIIpan were analyzed. The most common alleles in
geographic regions were determined using the IEDB population
coverage epitope analysis. Alleles were grouped by supertype
as described [24]. The list of all alleles, alleles grouped by
population region, alleles grouped by supertype, and all
epitopes used in this study are provided in Tables S1, S2, S3,
and S4.
Analysis of promiscuity
Binding prediction values were obtained from
NetMHCIIpan-2.0 for HLA-DR alleles, and NetMHCpan-2.0 for
HLA-A and HLA-B alleles. The two methods give the output
binding scores as 1 – log(aff), where aff is the IC50 value in
nM. Thus the scores range from 0 to 1, with higher scores
indicating higher affinity. We used a receiver operating
characteristic (ROC) curve to obtain a threshold prediction
value to specify which epitope/alleles combinations were
predicted to interact. To construct the ROC curves we ran
NetMHCpan-2.0 and NetMHCIIpan-2.0 against their published
validation datasets. We plotted the true positive rate (TPR)
against the false positive rate (FPR) at different thresholds of
binding from 0 to 1. We chose a FPR of 0.05, which
corresponded to thresholds of 0.29 for netMHCpan and 0.585
for netMHCIIpan, and TPRs of 0.89 for HLA class I and 0.24 for
HLA class II.
We defined promiscuity as the percent of allotypes each
epitope was predicted to bind to at each HLA locus. To analyze
overall promiscuity of epitopes from each pathogen species,
we calculated the mean promiscuity of each group, and
compared them with a one-way ANOVA and Tukey post-test
using GraphPad Prism 5. We only included epitopes predicted
to bind at least one allele in the analyses. To complement this
we performed kernel density estimation using reflection for
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boundary support [25] to estimate the probability density of
epitope promiscuity using MATLAB version 7.13.0.564. This
was based on a normal kernel function. The density was
evaluated at 101 equally spaced points in the interval [0,100].
The probability distribution of points lying outside the relevant
region of [0,100], specifically those in the intervals [-100,0] and
[100, 200], was reflected onto the distribution between 0 and
100 to arrive at the complete probability distribution. A
bandwidth parameter of 15 was used for smoothing the curves.
Distributions shifted to the right of the graph indicate higher
promiscuity. Epitope promiscuity was analyzed in this way
across all HLA alleles, as well as across HLA alleles grouped
by population region and by supertype. Analysis of HLA allele
promiscuity was carried out in the same way, with promiscuity
defined as the percent of epitopes each allotype was predicted
to bind each epitope at each HLA locus.
Results
Validation of the netMHCpan and netMHCIIpan methods
The accuracy of the netMHCpan and netMHCIIpan
prediction methods has been extensively validated by several
previous studies. One study compared experimentally
determined peptide-MHC binding affinities with affinities
predicted by three different algorithm prediction methods [26].
The authors found a positive correlation between predicted and
experimentally determined affinities, and found that this
correlation was strongest for the netMHCpan method. Another
study evaluated the prediction methods for a larger dataset
including alleles that were not included in the set used to train
the programs, using a comparison with experimental data from
the Immune Epitope Database (IEDB), and showed that the
netMHCpan ANN method was top ranking for both affinity and
ligand data [27]. In this analysis the authors removed peptides
used in program training as well as peptides in the IEDB that
had been identified using netMHCpan methods, in order to
remove any bias in favor of the netMHCpan methods. An
additional study conducted similar, independent evaluations of
MHC class I [28] and MHC class II [29] prediction methods,
and also found that netMHCpan and netMHCIIpan were
consistently the most accurate method when compared with
experimental results.
We conducted our own validation studies of the netMHCpan
and netMHCIIpan methods by running them against
experimental validation datasets. We constructed receiver
operating characteristic (ROC) curves for both the methods
and confirmed that both methods performed significantly better
than random guessing (see Methods). Based on the ROC
curve we chose threshold levels for netMHCpan and
netMHCIIpan such that the false positive rate (FPR) of
detecting epitope binding was 0.05 (Figure S1). This
corresponded to a true positive rate (TPR) of 0.89 for HLA
class I and 0.24 for HLA class II.
HLA alleles and microbe-derived epitopes.  We analyzed
all HLA-A and HLA-B, and HLA-DR alleles covered by
netMHCpan and netMHCIIpan. We analyzed microbe-derived
epitopes in four groups: Bacillus anthracis and Clostridium
tetani, Streptococcus pyogenes, Mycobacterium tuberculosis
complex, and Human immunodeficiency virus (HIV). B.
anthracis and C. tetani were grouped together in all analyses
because we found no significant differences between them in
mean epitope promiscuity across all alleles (data not shown).
These groups were selected for their biological diversity as
indicated above, and because epitope information was readily
available for each in the IEDB. We included all epitopes
available for each pathogen in each database at the time of
analysis. Supplementary Tables 1 and 2 provide lists of the
alleles and epitopes included in this study.
Promiscuity across all HLA-DR, -A, -B alleles and
epitopes.  To compare promiscuity between groups, we first
determined the percent of alleles that each epitope was
predicted to bind and computed mean promiscuity of epitopes
from each group. This revealed that epitopes in B. anthracis
and C. tetani were most promiscuous across all human HLA-
DR, HLA-A and HLA-B alleles (Figure 1), though there was no
significant difference in mean promiscuity between B. anthracis
and C. tetani and HIV across HLA-DR alleles (Figure 1A). In
addition we plotted distributions of the probability density of
epitope binding to increasing percentages of HLA alleles using
kernel density estimation (see Methods). Each distribution
shifted to the right for B. anthracis and C. tetani, indicating that
these epitopes were more likely to bind a greater breadth of
HLA alleles, which was consistent with the mean promiscuity
analysis (Figure 1). HIV epitopes were more promiscuous than
M. tuberculosis and S. pyogenes epitopes across HLA-DR
alleles (Figure 1A). M. tuberculosis epitopes were more
promiscuous than HIV and S. pyogenes epitopes across HLA-
A alleles by both analyses, and there was no difference
between S. pyogenes and HIV (Figure 1B). HIV epitopes were
less promiscuous than all groups across HLA-B alleles, and
there was no significant difference between M. tuberculosis
and S. pyogenes (Figure 1C). We found that using higher or
lower threshold values did not alter the results (data not
shown). Therefore, while B. anthracis and C. tetani epitopes
were most promiscuous, there was no consistent trend in
epitope promiscuity between the other pathogens that
extended to multiple HLA loci.
Although we were primarily interested in epitope promiscuity,
the study could also have been framed in terms of the ability of
HLA molecules to bind multiple epitopes [10]. Therefore we
performed the above analyses for predicted HLA allele
promiscuity. We found nearly identical trends to those we found
for epitope promiscuity using mean promiscuity analysis
(Figure S2). Kernel density estimations were also similar
(Figure S2). Thus, given the available data we cannot clearly
distinguish the effect of epitope promiscuity from HLA allele
promiscuity. However, for simplicity, we chose to focus only on
epitope promiscuity in all subsequent analyses.
Promiscuity across the most common HLA-DR, -A, -B
alleles in each geographic region.  The majority of the alleles
used in the above analysis are found at very low frequencies in
the human population. Thus we were interested in whether
patterns would be more distinct, or if new patterns would
emerge, if we focused on only the alleles most prevalent in
specific geographic regions. We grouped populations into
Europe and the Americas, East Asia, Sub-Saharan Africa, India
T Cell Epitope Promiscuity in Diverse Pathogens
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and East Africa, and Oceania (Table S3) and analyzed the
most prevalent alleles in these regions that comprised 60% of
the population. We chose these groups because they follow
human migration patterns [30] and, correspondingly, HLA
Figure 1.  T cell epitope promiscuity across HLA-DR, -A, -B alleles.  Kernel density estimates of epitope promiscuity and graphs
of mean epitope promiscuity (see Methods) of B. anthracis and C. tetani (BA & CT; blue), S. pyogenes and (SP; purple), HIV
(green) and M. tuberculosis complex (MTBC; orange) across HLA-DR (A), HLA-A (B) and HLA-B (C) alleles. Significant differences
in mean promiscuity between groups are indicated with black bars (Tukey’s post-test, p < 0.05). Error bars represent the standard
error of the mean.
doi: 10.1371/journal.pone.0073124.g001
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alleles are grouped this way in the dbMHC database.
Interestingly, the spread and divergence of pathogens like M.
tuberculosis also follow these migration patterns [31].
We found that patterns of promiscuity within geographic
regions (Figures 2-4) were similar, though not identical, to
those found across all alleles (Figure 1). B. anthracis and C.
tetani epitopes were most promiscuous across HLA-DR alleles
by both analyses in Sub-Saharan African and India and East
Africa (Figure 2C-D). S. pyogenes epitopes were least
promiscuous in all regions, although the differences in mean
promiscuity were not statistically significant for all pair wise
comparisons (Figure 2A–E). There was no striking difference in
epitope promiscuity across HLA-DR alleles between M.
tuberculosis and HIV in all regions except Oceania, where HIV
epitopes were more promiscuous (Figure 2A–E). We found that
B. anthracis and C. tetani epitopes were most promiscuous
across HLA-A alleles in all geographic regions (Figure 3A–E).
The other three groups had similar levels of promiscuity in all
regions. M. tuberculosis epitopes were more promiscuous in
East Asia and Sub-Saharan Africa (Figure 3B,C), and S.
pyogenes epitopes were more promiscuous in Oceania (Figure
3E). B. anthracis and C. tetani and S. pyogenes epitopes were
most promiscuous across HLA-B alleles in all regions, though
this trend was not distinct for S. pyogenes by the Kernel
density estimation (Figure 4A–E). M. tuberculosis epitopes
were more promiscuous than HIV epitopes in Europe and the
Americas, East Asia, and Oceania (Figure 4A,B,E), however
there was no striking difference between M. tuberculosis and
HIV in Sub-Saharan Africa and India and East Africa (Figure
4C,D).
Promiscuity within allele supertypes.  Despite being
highly polymorphic, HLA alleles can be organized into groups
that retain similar characteristics with overlapping peptide-
binding repertoires, known as supertypes [24]. Supertypes
were not specific to population region, as we found a diverse
collection of supertypes in each of the allele groups used in the
population analysis (data not shown). Thus, we looked at
whether there would be trends in epitope promiscuity within
groups of alleles with similar characteristics. Supertypes have
been best defined for HLA class I alleles [24], therefore for this
analysis we focused on HLA-A and HLA-B (Table S4). Using
mean promiscuity analysis, we found that B. anthracis and C.
tetani were most promiscuous within three of four HLA-A
supertypes, and that there was no trend between S. pyogenes,
HIV and M. tuberculosis (Figure S3). There was also no striking
trend between any of the pathogen groups within HLA-B
supertypes (Figure S3).
Discussion
In this study we compared T cell epitope promiscuity
between ecologically diverse pathogens with different antigenic
diversities. Epitope promiscuity has been shown both
experimentally and computationally for peptides derived from
different pathogens, including the human papillomavirus [16],
HIV [11,15,17,18], and M. tuberculosis [14,32], among others
[9,10,12,13]. However, to our knowledge, this is the first study
that directly compares promiscuity in multiple pathogens. We
found that B. anthracis and C. tetani were the most
promiscuous epitope group in the majority of the analyses, and
we found no trend in epitope promiscuity between HIV, M.
tuberculosis and S. pyogenes. These latter pathogens have
extremely different infection strategies and life cycles; thus if
there were marked differences in promiscuity between species
they should have been detected by our analyses. Importantly,
there is no established standard for epitope promiscuity that
allows determination whether groups of epitopes are highly
promiscuous or not.
The impact of epitope promiscuity on the outcomes of host–
pathogen interactions remains to be determined. Promiscuity
could benefit the host by increasing the number of antigenic
peptides that HLA molecules can present to T cells. This large
pool of peptides could also allow for selection of
immunodominant peptides that elicit the strongest T cell
responses [33]. If this is the case, vaccines containing
promiscuous epitopes should be especially effective; and this
has been suggested by several studies [34-38]. Our results
also showed that epitopes derived from successful vaccine
targets, B. anthracis and C. tetani epitopes, were the most
promiscuous. Alternatively, peptides recognized by many HLA
molecules in a population could predispose to immune
exhaustion and transmission of pathogens pre-adapted to the
immune response. In this context, promiscuity would be
harmful to the host. A recent study of HIV found that HLA
molecules associated with slow disease progression also had
the lowest levels of promiscuity [39]. The authors propose that
carrying HLA molecules with promiscuous binding repertoires
makes an individual “functionally homozygous” at the HLA
locus, and therefore decreases the heterozygote advantage of
having greater HLA allele diversity.
An unexpected finding in the present study is that conserved
M. tuberculosis epitopes and variable HIV epitopes have
similar breadths of HLA binding. Pathogens evolve variable
epitopes because they are less likely to be recognized by one
or more of the diverse HLA alleles [5,6]. Therefore, one
explanation for the evolution of hyperconserved epitopes is that
M. tuberculosis actually benefits from recognition [8]. If
promiscuity enhances the host’s ability to recognize pathogens,
then we might have expected M. tuberculosis epitopes to be
more promiscuous than HIV or S. pyogenes epitopes. As this
was not the case, we consider the idea that promiscuity does
not globally enhance immune recognition because it diminishes
the heterozygote advantage [39]. Whether pathogens benefit
from recognition or aim to avoid recognition, they are evolving
to exploit the host, presumably to the detriment of the host.
Thus, regardless of infection strategy, antagonistic coevolution
could emerge: the host benefits from generating new HLA
allele combinations that the pathogen has not yet adapted to,
and the pathogen benefits from evolving a way to diminish the
new HLA diversity. In this manner M. tuberculosis, HIV, and S.
pyogenes could have similar extents of promiscuity because
each benefits in a similar manner from promiscuous epitopes.
Interestingly, although immune evasion through antigenic
variation is the main strategy used by HIV, it has recently been
shown that a subset of HIV epitopes is selectively
hyperconserved [40]. Similarly, while the majority of identified
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Figure 2.  T cell epitope promiscuity across the most common HLA-DR alleles in geographic regions.  Kernel density
estimates of epitope promiscuity and graphs of mean epitope promiscuity (see Methods) of B. anthracis and C. tetani (BA & CT;
blue), S. pyogenes and (SP; purple), HIV (green) and M. tuberculosis complex (MTBC; orange) across the most common HLA-DR
alleles in Europe and the Americas (A), East Asia (B), Sub-Saharan Africa (C), India and East Africa (D) and Oceania (E).
Significant differences in mean promiscuity between groups are indicated with black bars (Tukey’s post-test, p < 0.05). Error bars
represent the standard error of the mean.
doi: 10.1371/journal.pone.0073124.g002
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Figure 3.  T cell epitope promiscuity across the most common HLA-A alleles in geographic regions.  Kernel density
estimates of epitope promiscuity and graphs of mean epitope promiscuity (see Methods) of B. anthracis and C. tetani (BA & CT;
blue), S. pyogenes and (SP; purple), HIV (green) and M. tuberculosis complex (MTBC; orange) across the most common HLA-A
alleles in Europe and the Americas (A), East Asia (B), Sub-Saharan Africa (C), India and East Africa (D) and Oceania (E).
Significant differences in mean promiscuity between groups are indicated with black bars (Tukey’s post-test, p < 0.05). Error bars
represent the standard error of the mean.
doi: 10.1371/journal.pone.0073124.g003
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Figure 4.  T cell epitope promiscuity across the most common HLA-B alleles in geographic regions.  Kernel density
estimates of epitope promiscuity and graphs of mean epitope promiscuity (see Methods) of B. anthracis and C. tetani (BA & CT;
blue), S. pyogenes (SP; purple), HIV (green) and M. tuberculosis complex (MTBC; orange) across the most common HLA-B alleles
in Europe and the Americas (A), East Asia (B), Sub-Saharan Africa (C), India and East Africa (D) and Oceania (E). Significant
differences in mean promiscuity between groups are indicated with black bars (Tukey’s post-test, p < 0.05). Error bars represent the
standard error of the mean.
doi: 10.1371/journal.pone.0073124.g004
T Cell Epitope Promiscuity in Diverse Pathogens
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M. tuberculosis epitopes are highly conserved, a small subset
of M. tuberculosis epitopes is variable [8]. It has been proposed
that recognition of specific subsets of epitopes may benefit the
host or the pathogens during specific stages of the infection.
Thus, it is tempting to speculate that epitope promiscuity is a
characteristic associated with specific subsets of epitopes –
e.g. the epitopes promoting pathogen virulence. Testing this
hypothesis by focusing our analysis on these sub-groups would
be the next step to determine whether promiscuity depends on
the conservation of epitopes or on the virulence cycle of the
pathogen.
The advantage of using algorithm-based methods was that
we were able to generate data for almost any epitope-HLA
combination. In this study we were primarily interested in the
potential for different epitopes to bind a diverse array of HLA
alleles, and any inconsistencies between the algorithm
predictions and biological reality will have applied equally to
each pathogen group. In vitro binding assays can be used to
complement computational methods by directly testing the
ability of epitopes to compete with other peptides known to bind
HLA molecules, however there are also limits to computer-
based and in vitro systems. Peptides that bind most strongly to
HLA molecules do not necessarily elicit the strongest T cell
responses [9,41], and thus these methods are not infallible for
identifying immunodominant peptides. Techniques that
facilitate further discovery of the determinants of peptide
epitope generation and recognition, together with the kinetics of
epitope generation and presentation during the course of
infection [42], will have a major impact on understanding the
impact of promiscuity on infection.
Conclusions
We used computer-based algorithms to compare the ability
of epitopes from a variety of pathogens to bind multiple of the
diverse HLA alleles. We found similar levels of epitope
promiscuity in HIV, M. tuberculosis and S. pyogenes, despite
differences in biology and epitope diversity. We propose a
model where promiscuity benefits a broad range of successful
human pathogens because it decreases the functional diversity
of HLA alleles in the human population. Studies that examine
the binding repertoire of epitopes presented at different stages
of human infection will be important to further our
understanding of how promiscuity influences host–pathogen
interaction, and how it could be incorporated into vaccine
design or disease management.
Supporting Information
Figure S1.  Receiver operator characteristic (ROC) curves
for netMHCpan and netMHCIIpan.  ROC curves were
generated by running NetMHCpan-2.0 and NetMHCIIpan-2.0
against their published validation datasets. The true positive
rate (TPR) is plotted against the false positive rate (FPR) at
different thresholds of binding from 0 to 1. For subsequent
analyses we chose a FPR of 0.05, which corresponded to
thresholds of 0.29 for netMHCpan and 0.585 for netMHCIIpan,
and TPRs of 0.89 for HLA class I and 0.24 for HLA class II.
(TIF)
Figure S2.  HLA-DR, -A, -B allele promiscuity across all
epitopes.  Kernel density estimates of epitope promiscuity and
graphs of mean HLA allele promiscuity (see Methods) of B.
anthracis and C. tetani (BA & CT; blue), S. pyogenes and (SP;
purple), HIV (green) and M. tuberculosis complex (MTBC;
orange) across HLA-DR (A), HLA-A (B) and HLA-B (C) alleles.
Differences in mean promiscuity are indicated with black bars
(Tukey’s post-test, p < 0.05). Error bars represent the standard
error of the mean.
(TIF)
Figure S3.  T cell epitope promiscuity across HLA class I
alleles grouped by supertype.  Graphs of mean epitope
promiscuity (see Methods) of B. anthracis and C. tetani (BA
and CT), S. pyogenes and (SP), HIV and M. tuberculosis
complex (MTBC) across alleles within HLA-A supertypes (A01,
A02, A03, A24) and within HLA-B supertypes (B07, B08, B27,
B44, B58, B62). For simplicity, Tukey post-tests are not shown
because no trend was found between the groups.
(TIF)
Table S1.  All epitopes used in this study.  The first column
refers to the IEDB reference number for bacterial epitopes, and
amino acid sequence for HIV epitopes. The second column
refers to the microbe group from which the epitope was
derived. The third column refers to the protein from which the
epitope was derived. The fourth column refers to the class of
HLA alleles that the epitopes have been shown to bind, and the
class in which they were analyzed in this study.
(PDF)
Table S2.  All HLA-DR, -A, -B alleles used in this
study.  (PDF)
Table S3.  Alleles grouped by population region.  (PDF)
Table S4.  Alleles grouped by supertype.  (PDF)
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